https://www.ambergen.com/wp-content/uploads/logo-retina.png00Kenneth Rothschildhttps://www.ambergen.com/wp-content/uploads/logo-retina.pngKenneth Rothschild2018-01-25 07:37:572018-04-25 07:47:37AmberGen awarded $2 million, 2-year Phase IIb SBIR grant from NIH-NIAID to further develop its PC-PURE™-assisted, multiplex, in vitro AllerBead™ assay which uses finger-stick blood for the highly multiplex quantification of allergen-specific IgE